Tracy Speight, MD
Obstetrics & Gynecology · Dallas, TXNPI 1831143148
Payments from drug & device makers
Across 66 payments — averaging $219.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$12K
- Celularity Inc.$1K
- Astellas Pharma US Inc$243
- AbbVie$181
- Pfizer$109
- Gynesonics, Inc.$89
- plus $550 from 16 others
What the payments were for
- Speaking & faculty fees$1,20048%
- Food & beverage$1,21149%
- Education$733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 9 | $12,113 |
| Celularity Inc. | 4 | $1,200 |
| Astellas Pharma US Inc | 10 | $243 |
| AbbVie(2 entities) | 9 | $181 |
| Pfizer | 6 | $109 |
| Gynesonics, Inc. | 2 | $89 |
| Millicent US Inc | 4 | $87 |
| Mayne Pharma Commercial LLC | 3 | $73 |
| Minerva Surgical, Inc | 2 | $69 |
| Organon | 3 | $63 |
| Channel Medsystems, Inc. | 1 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Ascend Therapeutics US, LLC | 2 | $27 |
| Innovation Technologies Inc | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $21 |
| Aspira Women's Health Inc | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Amgen | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Myovant Sciences Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $14 |
How this compares
$14,484 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 41 | $2,204 |
| ProgesteroneProgesterone, Micronized | 18 | $806 |
| Zolpidem Tartrate | 16 | $125 |
| Alprazolam | 18 | $41 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dallas
- Clark GriffithDallas$1.3M
- Liesl BredesonDallas$964K
- Anna Lizama ClarkDallas$869K
- Dale StovallDallas$590K
- Stephanie SlocumDallas$470K
- Jeffrey NelsonDallas$354K
- A StaubDallas$328K
- Francesca PeruginiDallas$255K
- Quanita CrableDallas$176K
- Yolanda LawsonDallas$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.